WASHINGTON — Total U.S. health care spending growth is expected to average 5.8% in aggregate over the 2014-2024 period, according to a report published in Health Affairs and written by members of the Centers for Medicare & Medicaid Services’ Office of the Actuary. The authors note that this rate of growth is still substantially lower
ALEXANDRIA, Va. — The National Community Pharmacists Association has called on Congress, Medicare and industry stakeholders to strike a balance in stamping out fraud in Medicare Part D while preserving patient access to critical medications. In comments submitted on Tuesday in conjunction with a House Energy and Commerce subcommittee hearing, titled “Medicare Part D: Measures
ALEXANDRIA, Va. — Eleven congressmen have asked the Centers for Medicare & Medicaid Services (CMS) for information on the enforcement of transparency measures for generic drug payments in Medicare Part D plans for 2016. The National Community Pharmacists Association said Thursday that this week U.S. Reps. Rick Allen (R., Ga.), Rod Blum (R., Iowa), Buddy
WASHINGTON — Providing incentives to prescription drug plan sponsors that increase generic drug use is among recommendations that the Senate Special Committee on Aging unveiled last month in a bipartisan report that focuses on ways to increase the utilization of generics within the Medicare Part D program. The panel also heard about industry issues beyond
